TUPELO — The key to treating congestive heart failure is addressing the underlying causes, and treatment is highly tailored to each patient's needs. Chris Bell, an acute care nurse practitioner who ...

TULSA, Okla. — Some people with congestive heart failure are getting the chance to try a new treatment. Saint Francis is in the middle of a two-year double-blind clinical trial for a device that could ...

You can follow a treatment plan and take medications as a doctor prescribes to manage congestive heart failure. Eat a ...

Corstasis Therapeutics Announces FDA Approval of ENBUMYST™ (bumetanide nasal spray) for the Treatment of Edema Associated with Congestive Heart Failure, Liver Disease and Kidney Disease ENBUMYST™ is ...

"Congestive Heart Failure Market Insight, Epidemiology and Market Forecast"DelveInsight Business Research's analysis underscores the transformative implications of the FDA's approval of ENBUMYST ...

When the heart struggles to pump efficiently, a cascade of events unfolds. Fluid accumulates in the lungs and extremities. Breathing becomes labored. Simple activities like climbing stairs or carrying ...

This article has been updated to better explain the effects anthracyclines can have on a patient's heart. Linda Newton has a faithful network to help her fight major diseases. "My family was very ...

Dr. Hare answers the question: 'Must I Repeat BNP Blood Tests?' — -- Question: Should the BNP blood test be repeated at each visit to my doctor, or at all? Answer: So the BNP test is a blood test ...

Dr. Hare answers the question: 'What Is An Assessment Of Volume Status?' — -- Question: What is an assessment of volume status, why is it important, and how is it done? Answer: Volume status is ...

Congestive Heart Failure Market drivers encompass demographic, clinical, and regulatory factors that collectively propel market expansion. The aging global population contributes to increased ...

New York, March 31, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Congestive Heart Failure Treatment Device Market - Premium Insight, Competitive News Feed ...

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell™ (ACP-01) to individuals suffering from peripheral arterial ...